{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:16:19Z","timestamp":1779891379378,"version":"3.53.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangxi science and technology base and talent project","award":["AC22080002"],"award-info":[{"award-number":["AC22080002"]}]},{"name":"Guangxi key research and development plan project","award":["AB22035080"],"award-info":[{"award-number":["AB22035080"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10875-025-01946-3","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T02:13:15Z","timestamp":1762740795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of Immune Cells on IgA Vasculitis via Metabolites and Inflammatory Cytokines"],"prefix":"10.1007","volume":"45","author":[{"given":"Ming","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"5","key":"1946_CR1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00281-021-00874-9","volume":"43","author":"E Pillebout","year":"2021","unstructured":"Pillebout E, Sunderk\u00f6tter C. IgA vasculitis. Semin Immunopathol. 2021;43(5):729\u201338.","journal-title":"Semin Immunopathol"},{"issue":"1","key":"1946_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41584-021-00718-8","volume":"18","author":"RA Watts","year":"2022","unstructured":"Watts RA, et al. Global epidemiology of vasculitis. Nat Rev Rheumatol. 2022;18(1):22\u201334.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"1946_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10067-020-05166-5","volume":"40","author":"L Du","year":"2021","unstructured":"Du L, et al. Multisystemic manifestations of IgA vasculitis. Clin Rheumatol. 2021;40(1):43\u201352.","journal-title":"Clin Rheumatol"},{"key":"1946_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.771619","volume":"12","author":"Y Song","year":"2021","unstructured":"Song Y, et al. Pathogenesis of IgA vasculitis: an up-to-date review. Front Immunol. 2021;12:771619.","journal-title":"Front Immunol"},{"issue":"3","key":"1946_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12016-015-8495-6","volume":"50","author":"P Renauer","year":"2016","unstructured":"Renauer P, Coit P, Sawalha AH. Epigenetics and vasculitis: a comprehensive review. Clin Rev Allergy Immunol. 2016;50(3):357\u201366.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"1946_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1001\/archderm.138.3.345","volume":"138","author":"JC Malone","year":"2002","unstructured":"Malone JC, et al. Vascular inflammation (vasculitis) in sweet syndrome: a clinicopathologic study of 28 biopsy specimens from 21 patients. Arch Dermatol. 2002;138(3):345\u20139.","journal-title":"Arch Dermatol"},{"issue":"2","key":"1946_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/BOR.0b013e32835d8e2a","volume":"25","author":"M Piram","year":"2013","unstructured":"Piram M, Mahr A. Epidemiology of immunoglobulin A vasculitis (Henoch-Sch\u00f6nlein): current state of knowledge. Curr Opin Rheumatol. 2013;25(2):171\u20138.","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"1946_CR8","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.autrev.2017.10.009","volume":"16","author":"MH Heineke","year":"2017","unstructured":"Heineke MH, et al. New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Sch\u00f6nlein purpura). Autoimmun Rev. 2017;16(12):1246\u201353.","journal-title":"Autoimmun Rev"},{"key":"1946_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.921864","volume":"13","author":"L Xu","year":"2022","unstructured":"Xu L, Li Y, Wu X. IgA vasculitis update: epidemiology, pathogenesis, and biomarkers. Front Immunol. 2022;13:921864.","journal-title":"Front Immunol"},{"issue":"2","key":"1946_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1089\/107999099314234","volume":"19","author":"G Krishnaswamy","year":"1999","unstructured":"Krishnaswamy G, et al. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res. 1999;19(2):91\u2013104.","journal-title":"J Interferon Cytokine Res"},{"key":"1946_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601.","journal-title":"BMJ"},{"issue":"12","key":"1946_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103210","volume":"21","author":"C Chen","year":"2022","unstructured":"Chen C, et al. Mendelian randomization as a tool to gain insights into the mosaic causes of autoimmune diseases. Autoimmun Rev. 2022;21(12):103210.","journal-title":"Autoimmun Rev"},{"issue":"10","key":"1946_CR13","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orr\u00f9","year":"2020","unstructured":"Orr\u00f9 V, et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020;52(10):1036\u201345.","journal-title":"Nat Genet"},{"issue":"9","key":"1946_CR14","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","volume":"24","author":"JH Zhao","year":"2023","unstructured":"Zhao JH, et al. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat Immunol. 2023;24(9):1540\u201351.","journal-title":"Nat Immunol"},{"issue":"1","key":"1946_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","volume":"55","author":"Y Chen","year":"2023","unstructured":"Chen Y, et al. Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. Nat Genet. 2023;55(1):44\u201353.","journal-title":"Nat Genet"},{"issue":"2","key":"1946_CR16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"1946_CR17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, et al. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314.","journal-title":"Genet Epidemiol"},{"issue":"7","key":"1946_CR18","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658\u201365.","journal-title":"Genet Epidemiol"},{"issue":"6","key":"1946_CR19","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","volume":"46","author":"FP Hartwig","year":"2017","unstructured":"Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985\u201398.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"1946_CR20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138.","journal-title":"Nat Genet"},{"issue":"3","key":"1946_CR21","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755\u201364.","journal-title":"Int J Epidemiol"},{"issue":"12","key":"1946_CR22","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1007\/s10067-023-06781-8","volume":"42","author":"CEC Williams","year":"2023","unstructured":"Williams CEC, et al. A narrative review of potential drug treatments for nephritis in children with IgA vasculitis (HSP). Clin Rheumatol. 2023;42(12):3189\u2013200.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"1946_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.autrev.2017.11.024","volume":"17","author":"R L\u00f3pez-Mej\u00edas","year":"2018","unstructured":"L\u00f3pez-Mej\u00edas R, et al. Genetics of immunoglobulin-A vasculitis (Henoch-schonlein purpura): an updated review. Autoimmun Rev. 2018;17(3):301\u201315.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"1946_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10157-018-1665-0","volume":"23","author":"J Ruszkowski","year":"2019","unstructured":"Ruszkowski J, et al. T cells in IgA nephropathy: role in pathogenesis, clinical significance and potential therapeutic target. Clin Exp Nephrol. 2019;23(3):291\u2013303.","journal-title":"Clin Exp Nephrol"},{"issue":"8","key":"1946_CR25","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s00467-015-3051-4","volume":"30","author":"B G\u00fclhan","year":"2015","unstructured":"G\u00fclhan B, et al. Studying cytokines of T helper cells in the kidney disease of IgA vasculitis (Henoch-Schonlein purpura). Pediatr Nephrol. 2015;30(8):1269\u201377.","journal-title":"Pediatr Nephrol"},{"key":"1946_CR26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fimmu.2019.00010","volume":"10","author":"HZ Liu","year":"2019","unstructured":"Liu HZ, et al. CD8+CD122+PD-1+Tregs synergize with costimulatory blockade of CD40\/CD154, but Not B7\/CD28, to prolong murine allograft survival. Front Immunol. 2019;10:10.","journal-title":"Front Immunol"},{"issue":"6","key":"1946_CR27","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1053\/j.gastro.2006.09.008","volume":"131","author":"I M\u00e9nager-Marcq","year":"2006","unstructured":"M\u00e9nager-Marcq I, et al. CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice. Gastroenterology. 2006;131(6):1775\u201385.","journal-title":"Gastroenterology"},{"issue":"2","key":"1946_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/1042819031000151932","volume":"45","author":"MH Dahlke","year":"2004","unstructured":"Dahlke MH, et al. The biology of CD45 and its use as a therapeutic target. Leuk Lymphoma. 2004;45(2):229\u201336.","journal-title":"Leuk Lymphoma"},{"key":"1946_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1146\/annurev.immunol.16.1.201","volume":"16","author":"RW Dutton","year":"1998","unstructured":"Dutton RW, Bradley LM, Swain SL. T cell memory. Annu Rev Immunol. 1998;16:201\u201323.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"1946_CR30","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4049\/jimmunol.167.1.212","volume":"167","author":"JM Faint","year":"2001","unstructured":"Faint JM, et al. Memory T cells constitute a subset of the human CD8+CD45RA+ pool with distinct phenotypic and migratory characteristics. J Immunol. 2001;167(1):212\u201320.","journal-title":"J Immunol"},{"issue":"5","key":"1946_CR31","first-page":"418","volume":"25","author":"L Claude","year":"2005","unstructured":"Claude L, et al. Significance of unconventional peripheral CD4+CD8dim T cell subsets. J Clin Immunol. 2005;25(5):418\u201327.","journal-title":"J Clin Immunol"},{"issue":"11","key":"1946_CR32","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1038\/s12276-023-01105-x","volume":"55","author":"CH Koh","year":"2023","unstructured":"Koh CH, et al. CD8 t-cell subsets: heterogeneity, functions, and therapeutic potential. Exp Mol Med. 2023;55(11):2287\u201399.","journal-title":"Exp Mol Med"},{"issue":"2","key":"1946_CR33","doi-asserted-by":"publisher","first-page":"676","DOI":"10.4049\/jimmunol.1003884","volume":"187","author":"A Clayton","year":"2011","unstructured":"Clayton A, et al. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J Immunol. 2011;187(2):676\u201383.","journal-title":"J Immunol"},{"issue":"42","key":"1946_CR34","doi-asserted-by":"publisher","first-page":"28480","DOI":"10.1074\/jbc.M800039200","volume":"283","author":"R Corriden","year":"2008","unstructured":"Corriden R, et al. Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1\/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine. J Biol Chem. 2008;283(42):28480\u20136.","journal-title":"J Biol Chem"},{"issue":"5","key":"1946_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037100","volume":"7","author":"C Blume","year":"2012","unstructured":"Blume C, et al. Autoimmunity in CD73\/ecto-5\u2032-nucleotidase deficient mice induces renal injury. PLoS ONE. 2012;7(5):14.","journal-title":"PLoS ONE"},{"issue":"4","key":"1946_CR36","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","volume":"110","author":"G Borsellino","year":"2007","unstructured":"Borsellino G, et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007;110(4):1225\u201332.","journal-title":"Blood"},{"issue":"4","key":"1946_CR37","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.jaci.2010.02.018","volume":"125","author":"AM Vale","year":"2010","unstructured":"Vale AM, Schroeder HW. Clinical consequences of defects in B-cell development. J Allergy Clin Immunol. 2010;125(4):778\u201387.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1946_CR38","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s10067-020-04996-7","volume":"39","author":"L Bergantini","year":"2020","unstructured":"Bergantini L, et al. Effects of rituximab therapy on B cell differentiation and depletion. Clin Rheumatol. 2020;39(5):1415\u201321.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"1946_CR39","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1182\/blood-2003-07-2332","volume":"102","author":"TJ Hamblin","year":"2003","unstructured":"Hamblin TJ. CD38: what is it there for? Blood. 2003;102(6):1939\u201340.","journal-title":"Blood"},{"key":"1946_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jneuroim.2019.05.004","volume":"332","author":"SS Jing","year":"2019","unstructured":"Jing SS, et al. Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis. J Neuroimmunol. 2019;332:216\u201323.","journal-title":"J Neuroimmunol"},{"key":"1946_CR41","first-page":"91","volume":"2","author":"D Hahn","year":"2023","unstructured":"Hahn D, Hodson EM, Craig JC. Interventions for preventing and treating kidney disease in IgA vasculitis. Cochrane Database Syst Rev. 2023;2:91.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1946_CR42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/MOP.0b013e3282f4308b","volume":"20","author":"JT Sanders","year":"2008","unstructured":"Sanders JT, Wyatt RJ. IgA nephropathy and Henoch-schonlein purpura nephritis. Curr Opin Pediatr. 2008;20(2):163\u201370.","journal-title":"Curr Opin Pediatr"},{"issue":"48","key":"1946_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/MD.0000000000031219","volume":"101","author":"E Habas","year":"2022","unstructured":"Habas E, et al. IgA nephropathy pathogenesis and therapy: review & updates. Medicine (Baltimore). 2022;101(48):7.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"1946_CR44","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.coi.2011.10.007","volume":"23","author":"S Pillai","year":"2011","unstructured":"Pillai S, Mattoo H, Cariappa A. B cells and autoimmunity. Curr Opin Immunol. 2011;23(6):721\u201331.","journal-title":"Curr Opin Immunol"},{"key":"1946_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.859502","volume":"13","author":"R Watanabe","year":"2022","unstructured":"Watanabe R, Hashimoto M. Pathogenic role of monocytes\/macrophages in large vessel vasculitis. Front Immunol. 2022;13:11.","journal-title":"Front Immunol"},{"issue":"5","key":"1946_CR46","first-page":"278","volume":"12","author":"S Kumar","year":"2006","unstructured":"Kumar S, Jack R. Origin of monocytes and their differentiation to macrophages and dendritic cells. J Endotoxin Res. 2006;12(5):278\u201384.","journal-title":"J Endotoxin Res"},{"key":"1946_CR47","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/annrheumdis-2021-eular.1623","volume":"80","author":"S Deshayes","year":"2021","unstructured":"Deshayes S, et al. Steroid-sparing effect of anakinra in giant-cell arteritis: a case series with clinical, biological and iconographic long-term assessments. Ann Rheum Dis. 2021;80:397\u2013397.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1946_CR48","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0014-5793(89)80476-4","volume":"242","author":"JV Castell","year":"1989","unstructured":"Castell JV, et al. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 1989;242(2):237\u20139.","journal-title":"FEBS Lett"},{"issue":"10","key":"1946_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108757","volume":"24","author":"H Williams","year":"2023","unstructured":"Williams H, et al. Monocyte differentiation and heterogeneity: inter-subset and interindividual differences. Int J Mol Sci. 2023;24(10):24.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1946_CR50","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/rheumatology\/kel128","volume":"45","author":"MC Cid","year":"2006","unstructured":"Cid MC, et al. Association between increased CCL2 (MCP-1) expression in lesions and persistence of disease activity in giant-cell arteritis. Rheumatology. 2006;45(11):1356\u201363.","journal-title":"Rheumatology"},{"issue":"2","key":"1946_CR51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/path.2287","volume":"214","author":"JR Bradley","year":"2008","unstructured":"Bradley JR. TNF-mediated inflammatory disease. J Pathol. 2008;214(2):149\u201360.","journal-title":"J Pathol"},{"key":"1946_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.148910","volume":"1839","author":"S Li","year":"2024","unstructured":"Li S, et al. Oral application of magnesium-L-threonate alleviates radicular pain by inhibiting neuro-inflammation dependent central sensitization of rats. Brain Res. 2024;1839:148910.","journal-title":"Brain Res"},{"issue":"3","key":"1946_CR53","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/ecco-jcc\/jjac149","volume":"17","author":"N Nystr\u00f6m","year":"2023","unstructured":"Nystr\u00f6m N, et al. Mucosal and plasma metabolomes in new-onset paediatric inflammatory bowel disease: correlations with disease characteristics and plasma inflammation protein markers. J Crohns Colitis. 2023;17(3):418\u201332.","journal-title":"J Crohns Colitis"},{"key":"1946_CR54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.vph.2016.09.005","volume":"87","author":"E Zuccolo","year":"2016","unstructured":"Zuccolo E, et al. Arachidonic acid-evoked Ca(2+) signals promote nitric oxide release and proliferation in human endothelial colony forming cells. Vascul Pharmacol. 2016;87:159\u201371.","journal-title":"Vascul Pharmacol"},{"key":"1946_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2022.119501","volume":"290","author":"MA Ali","year":"2022","unstructured":"Ali MA, et al. 3-formylindole-based chitosan Schiff base polymer: Antioxidant and in vitro cytotoxicity studies on THP-1 cells. Carbohydr Polym. 2022;290:119501.","journal-title":"Carbohydr Polym"},{"key":"1946_CR56","unstructured":"Hay DW, Carey MC. Chemical species of lipids in bile. Hepatology, 1990. 12(3 Pt 2):6S-14S; discussion 14S-16S."},{"key":"1946_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123012","volume":"355","author":"J Wang","year":"2024","unstructured":"Wang J, et al. Clinical applications of phosphocreatine and related mechanisms. Life Sci. 2024;355:123012.","journal-title":"Life Sci"},{"issue":"1","key":"1946_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-024-03317-6","volume":"26","author":"M Baj\u017eelj","year":"2024","unstructured":"Baj\u017eelj M, et al. Deregulation in adult IgA vasculitis skin as the basis for the discovery of novel serum biomarkers. Arthritis Res Ther. 2024;26(1):85.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1946_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11970-7","volume":"12","author":"S Hosseinkhani","year":"2022","unstructured":"Hosseinkhani S, et al. Targeted metabolomics analysis of amino acids and acylcarnitines as risk markers for diabetes by LC-MS\/MS technique. Sci Rep. 2022;12(1):8418.","journal-title":"Sci Rep"},{"issue":"5","key":"1946_CR60","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1365-2265.2011.04244.x","volume":"76","author":"CY Ha","year":"2012","unstructured":"Ha CY, et al. The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes. Clin Endocrinol (Oxf). 2012;76(5):674\u201382.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1946_CR61","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.96101","author":"D Korenfeld","year":"2017","unstructured":"Korenfeld D, et al. A type of human skin dendritic cell marked by CD5 is associated with the development of inflammatory skin disease. JCI Insight. 2017. https:\/\/doi.org\/10.1172\/jci.insight.96101.","journal-title":"JCI Insight"},{"issue":"3","key":"1946_CR62","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013991","volume":"98","author":"B Li","year":"2019","unstructured":"Li B, et al. The change of Th17\/Treg cells and IL-10\/IL-17 in Chinese children with Henoch-Schonlein purpura: a PRISMA-compliant meta-analysis. Medicine (Baltimore). 2019;98(3):e13991.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1946_CR63","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10067-018-4234-8","volume":"38","author":"T Kuret","year":"2019","unstructured":"Kuret T, et al. Insight into inflammatory cell and cytokine profiles in adult IgA vasculitis. Clin Rheumatol. 2019;38(2):331\u20138.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"1946_CR64","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s10741-021-10153-2","volume":"27","author":"M Dutka","year":"2022","unstructured":"Dutka M, et al. Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases. Heart Fail Rev. 2022;27(4):1395\u2013411.","journal-title":"Heart Fail Rev"},{"issue":"1","key":"1946_CR65","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1515\/med-2020-0046","volume":"15","author":"M Migacz","year":"2020","unstructured":"Migacz M, et al. The role of osteoprotegerin in the development, progression and management of abdominal aortic aneurysms. Open Med (Wars). 2020;15(1):457\u201363.","journal-title":"Open Med (Wars)"},{"issue":"2","key":"1946_CR66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1515\/bjmg-2017-0021","volume":"20","author":"P Jia","year":"2017","unstructured":"Jia P, et al. Association between osteoprotegerin gene polymorphisms and risk of coronary artery disease: a systematic review and meta-analysis. Balkan J Med Genet. 2017;20(2):27\u201334.","journal-title":"Balkan J Med Genet"},{"issue":"3","key":"1946_CR67","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/08820139.2017.1423499","volume":"47","author":"RM Gamal","year":"2018","unstructured":"Gamal RM, et al. Study of the osteoprotegerin\/receptor activator of nuclear factor-kB ligand system association with inflammation and atherosclerosis in systemic sclerosis. Immunol Invest. 2018;47(3):241\u201350.","journal-title":"Immunol Invest"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01946-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-025-01946-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01946-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:02:12Z","timestamp":1777309332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-025-01946-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1946"],"URL":"https:\/\/doi.org\/10.1007\/s10875-025-01946-3","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study relied on publicly accessible summary statistics from previously published research and consortia. Each original study involved in this research had received ethical clearance from their respective review boards, and all participants had given informed consent. Notably, this research did not involve the use of individual-level data, thereby eliminating the need for new ethical review board approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Informed consent was obtained from all participants involved in this study for the publication of any identifying information and data. Participants were made aware of the purpose of the study and the nature of their contributions. All personal identifiers have been removed to protect participant anonymity.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}],"article-number":"157"}}